The CD28-TMDM4, but not the other TMD-mutants, abrogated the proliferation of CD3−CARlow cells and significantly reduced the proliferation of CD3−CARint cells with either CD8-HD or IgG4-HD (Figures 3B,C). The gene discussed is CD28; the disease is Huntington disease.